《新股消息》凌雄科技(02436.HK)公开发售下限定价7.6元 一手中签率30%
凌雄科技(02436.HK)公布招股结果,每股发售价定为7.6元,为招股价范围(7.6至8.74元)的下限定价,香港公开发售部分录得超额认购约5.16倍。每手300股计,一手中签率为30%,认购7手即2,100股稳获一手。该股将於明日(24日)挂牌。独家保荐人为海通国际。
公司上市料净集资约3.37亿元,预期约45%将用於改善客户体验,以满足不断演进的客户需求;25%将用於扩大公司在目标市场的客户群及市场份额;15%将用於系统升级和产品开发;5%将用於加强公司的风险管理能力;10%将用作营运资金及一般企业用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.